Perioperative management of anticoagulants has become routine for anesthesiologists.

Bleeding and thrombotic risks should be balanced when deciding upon management.

Warfarin is usually stopped 5-7 days prior for procedures with high bleeding risk.

Bridging should be considered for patients on warfarin at high thrombotic risk.

Novel anticoagulants can be stopped close to the procedure usually without bridging.